Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

You face real maintenance and sustainability issues when ceding coding control to AI. Having AI agents write your code is a lot like having human contractors write it. These best practices will help ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence.

xAI has launched a coding agent of its own to serve as competitor to its rivals' products, such as Anthropic's Claude Code. It's called Grok Build, and it's still in its early beta version that's ...

Cybersecurity vendor Trellix published a terse statement last Friday, disclosing that a threat actor recently gained unauthorized access to "a portion of our source code repository." Trellix did not ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. In ...

Microsoft Threat Intelligence presents a comprehensive analysis of The Gentlemen, a Go-based ransomware deployed by ...

Earlier this year, Recursion Pharmaceuticals Inc RXRX initiated discussions with the FDA for the design of a registrational study for its experimental drug REC-4881 in familial adenomatous polyposis ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...